Elite Supplement Center LLC and Elite Training Facility LLC sold unapproved new drug products containing selective androgen receptor modulators (SARMs)—including Ostarine MK-2866, Ligandrol LGD-4033, Ibutamoren MK-677, Testolone Rad-140, and Cardarine GW501516—in violation of the Federal Food, Drug, and Cosmetic Act. Despite labeling these products as "research only" and "not for human consumption," the company's website contained marketing claims explicitly describing health benefits such as lean muscle gains, bone health, and muscle recovery, establishing intent for human drug use. The FDA identified serious safety concerns with SARMs products, including documented cases of life-threatening liver toxicity and potential increased risk of heart attack and stroke in users.